Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Head and Neck Cancers
•
Radiation Oncology
Do you modify your treatment strategies for P16 positive oropharyngeal cancers in patients who also have a significant smoking history?
Related Questions
Do you use any thyroid dose constraints for head neck radiation planning?
What is the recommended adjuvant dose for neuroendocrine cancer in the head and neck?
Would you recommend adjuvant radiation for a patient with head/neck merkel cell carcinoma following a pathologic complete response to neoadjuvant immunotherapy?
How would you approach post-op radiation recommendations in patients who had neoadjuvant chemoimmunotherapy for HPV mediated OPSCC s/p TORS who have a complete pathologic response (pCR)?
What dose and regimen would you treat a stage I laryngeal cancer s/p R1 resection?
What is the recommended treatment approach for stage III/IVA nasopharyngeal cancer that is p16 negative and EBV positive?
Is there a role for prophylactic Trental and vitamin E in a patient at high risk for osteoradionecrosis?
How would you manage a presumed radiation induced sarcoma of the head and neck?
Would you consider 50 Gy in 20 fractions for a primary head and neck malignancy in an elderly patient with poor KPS?
What would your approach be for a locally advanced head and neck cancer diagnosed concurrently with a mid-esophageal cancer?
